drugset / Trial / NCT02848079
TAS-OX for Refractory Metastatic Colon Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study will examine the safety and effectiveness of oxaliplatin in combination with TAS-102 (TAS-OX) for treatment of patients with metastatic colorectal cancer whose cancer has progressed or recurred after FOLFOX chemotherapy.
Timeline
- Start
- 2016-10-31
- Primary completion
- 2020-06-02
- Completion
- 2020-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | Other |
| Subject | TAS-102 | Small molecule | — | Oral |